A

Agilent Technologies

Provides eProcurement automation and hosted catalogs

Account Manager - Chromatography/Mass Spec Instrument Sales

Full-TimeUpdated on 10/27/2026
$158k - $263.4k/yr+ Bonus eligibility + Stock
Mid
Bachelor's, Master's, PhD
La Jolla, San Diego, CA, USA
In PersonField-based territory covering San Diego County; remote-work option is available. Regular local travel; overnight travel is rare.
Sales & Account ManagementAccount Management
Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • A bachelor's, master's, or Ph.D. in chemistry, biology, or another applied science, or an equivalent combination of education and experience.
  • At least 4 years of field sales or account management experience in analytical instrumentation, laboratory technology, or scientific markets.
  • Hands-on knowledge of chromatography and mass spectrometry (GC, LC, GC/MS, LC/MS) in laboratory settings.
  • Experience selling capital analytical equipment through the full sales process, from prospecting and qualification to competitive positioning, negotiation, and close.
  • A proven record of meeting or exceeding quota, growing market share, and building a sustainable pipeline in a competitive territory.
  • Ability to independently manage complex opportunities with multiple decision-makers, technical requirements, funding considerations, and procurement processes.
  • Business acumen to set territory and account strategy and prioritize resources.
  • Communication, presentation, and negotiation skills to influence stakeholders at all levels, including executive leadership.
  • Experience leading cross-functional selling teams without direct authority.
  • Self-management, organization, and time-management skills.
  • Ability to travel regularly within San Diego County; overnight travel is rare.
  • A valid driver's license and a driving record that meets Agilent's fleet safety requirements.
Responsibilities
  • Own and deliver the territory quota, sales forecast, and market-share goals across chromatography, mass spectrometry, molecular spectroscopy, software, consumables, and services.
  • Build and execute a strategic territory plan targeting high-value segments, competitive opportunities, and untapped accounts.
  • Manage and grow strategic, multi-million-dollar accounts, building relationships from laboratory end users through operations, procurement, and C-suite leadership.
  • Generate demand through targeted prospecting, networking, workflow discovery, and new customer and application development.
  • Lead consultative sales cycles from first engagement through solution design, business justification, negotiation, and close.
  • Translate customer needs into differentiated workflow solutions and communicate technical, economic, and business value, including in executive presentations.
  • Partner with Product Specialists, Application Engineers, Consumables and Service teams, Customer Operations, Marketing, and other colleagues to win and support customers.
  • Lead competitive response on significant opportunities and resolve non-routine customer issues, escalating when needed.
  • Support local marketing programs, customer events, seminars, and lead-generation activities.
  • Maintain accurate monthly, quarterly, and half-year forecasts, along with disciplined Salesforce CRM, expense, and business-process practices.
Desired Qualifications
  • Established customer and industry network in the greater San Diego area.
  • Experience selling into environmental, clinical, food and beverage, chemical and energy, materials, forensics and toxicology, or commercial testing laboratories.
  • Experience managing strategic accounts, displacing incumbent competitors, and expanding wallet share across instruments, consumables, software, and services.
  • Familiarity with molecular spectroscopy, informatics, and applied-market workflows.
  • Advanced use of AI tools such as Microsoft Copilot for selling, including building prospecting campaigns, analyzing funnel health, researching territory and market data, and preparing customer materials, with careful human review for accuracy.
  • Advanced Salesforce CRM skills.
  • LC/MS experience is strongly preferred.

About the company

Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Get referred to Agilent Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY2026 revenue hit $1.88 billion, up 8.1%, and guidance rose to $7.51 billion.
  • China grew 9% and pharma grew 12%, signaling stronger end markets.
  • September 2026 launches, including S540MD and Gen5 AI, expand higher-value digital pathology.

What critics are saying

  • Tariff refunds added 110 basis points to Q3 margin, masking underlying profitability.
  • FY26 restructuring costs and workforce reductions continue through first-quarter 2027.
  • A failed pathology pivot leaves Agilent overexposed to slower instrument cycles and commoditization.

What makes Agilent Technologies unique

  • Agilent combines instruments, software, and consumables across pathology, imaging, and analytics.
  • The June 2026 Biocare Medical acquisition deepens its pathology menu and clinical reach.
  • June 2026 OpenAI and BCG collaboration pushes AI into products, operations, and workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Performance Bonus
  • Stock Options

Growth & Insights and Company News

6 month growth

3%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 13th, 2026
Agilent to buy digital pathology firm Proscia for $240M in cash

Agilent Technologies Inc. agreed to buy Proscia, a digital pathology software provider, in an all-cash deal valued at $240 million at closing. Proscia's founders could earn up to $30 million more if it meets future performance milestones. Proscia's software connects slide scanners, laboratory systems, and AI tools in one platform. It serves more than 4,000 laboratories, hospitals, and clinics, and 16 of the top 20 pharmaceutical companies. Its trailing twelve-month revenue exceeds $18 million. The companies have worked together since a September 2022 distribution agreement. Agilent expects Proscia's recurring-revenue software to add a high-growth, high-margin business to its pathology portfolio. The deal is subject to customary closing conditions and is expected to close early in Agilent's fiscal year 2027.

Business Wire
Sep 29th, 2026
Agilent launches Gen5 AI cell identification module for BioTek automated imagers

Agilent Technologies has launched the BioTek Gen5 AI cell identification module, a new image analysis software add-on for its BioTek automated imaging systems. The module uses AI-based cell identification and segmentation, eliminating the need for conventional threshold setting or parameter tuning. The technology addresses challenges researchers face with threshold-based segmentation, which requires establishing and optimising analysis parameters for individual experiments. This process can introduce user-dependent variation and create difficulties in high-throughput imaging workflows. The module supports label-free and fluorescence applications, as well as live-cell and kinetic assays commonly used in life science and pharmaceutical research. It integrates with Gen5 software, allowing researchers using compatible BioTek Cytation and Lionheart automated imagers to apply AI-based segmentation within existing workflows. Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.

Yahoo Finance
Sep 19th, 2026
Agilent launches 540-slide scanner for pathology labs eyeing AI workflows

Agilent Technologies launched the S540MD slide scanner in the United States on 4 September. The FDA-cleared device can hold up to 540 glass slides at once and targets pathology labs managing high sample volumes and preparing for AI-assisted workflows. The scanner automates routine tasks and integrates with existing laboratory setups. It reached select European markets in January and is now available in Germany, the UK, France, and other European countries alongside the US. Agilent reported revenue of $1.88 billion for the quarter ended 31 July, up 8.1% year-on-year. Non-GAAP earnings per share rose 18%. Management raised full-year non-GAAP earnings guidance to $6.18 to $6.21 per share. The S540MD is a rebadged Hamamatsu NanoZoomer S540MD. Agilent has not disclosed pricing or revenue targets for the product.

Associated Press
Sep 8th, 2026
Agilent appoints ex-Stryker CFO Glenn Boehnlein to board, chair Koh Boon Hwee retires

Agilent Technologies announced that Koh Boon Hwee retired from its board of directors on 4 September 2026, after more than 20 years of service. Koh joined the board in 2003 and served as independent chair from 2017 until his retirement. Dow R. Wilson, a board member since 2018, was elected as the new chair. Wilson currently chairs the Audit and Finance Committee. The company also appointed Glenn Boehnlein to its board, effective 4 September 2026. Boehnlein spent 22 years at Stryker Corporation, serving as vice president and chief financial officer from 2016 until his retirement in 2025. He currently serves on the boards of Inogen and Sutter Health.

Associated Press
Sep 1st, 2026
Agilent launches Cary 635 FTIR spectrometer for compact, high-performance lab analysis

Agilent Technologies has launched the Cary 635 FTIR spectrometer, described as the smallest Fourier transform infrared analyser in its class. The compact instrument combines high-performance analysis with user-friendly operation, requiring minimal technical training. The spectrometer features solid ZnSe optical components for enhanced moisture resistance and improved sensitivity for analysing lower-concentration samples. Its modular architecture supports analysis of solids, liquids, powders, and gases, whilst permanently aligned optics enable rapid interchange of sampling modules. The device includes MicroLab software with step-by-step workflows and colour-coded results, allowing novice users to be trained quickly. Agilent generated $6.95 billion in revenue during fiscal year 2025 and employs approximately 18,000 people worldwide.